Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Theriva Biologics Inc (AMEX: TOVX) closed at $0.46 in the last session, down -2.55% from day before closing price of $0.47. In other words, the price has decreased by -$2.55 from its previous closing price. On the day, 0.92 million shares were traded.
Ratios:
We take a closer look at TOVX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.53 and its Current Ratio is at 1.53. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.14.
Stock Price History:
Over the past 52 weeks, TOVX has reached a high of $7.37, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is -52.64%, while the 200-Day Moving Average is calculated to be -72.28%.
Shares Statistics:
A total of 8.19M shares are outstanding, with a floating share count of 8.10M. Insiders hold about 1.04% of the company’s shares, while institutions hold 2.33% stake in the company.
Earnings Estimates
The market rating for Theriva Biologics Inc (TOVX) is a result of the insights provided by 1 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.43, with high estimates of -$0.43 and low estimates of -$0.43.
Analysts are recommending an EPS of between -$2.2 and -$2.2 for the fiscal current year, implying an average EPS of -$2.2. EPS for the following year is -$0.95, with 1.0 analysts recommending between -$0.95 and -$0.95.
